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Diversity within the adenovirus ﬁber knob
hypervariable loops inﬂuences primary receptor
interactions
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Adenovirus based vectors are of increasing importance for wide ranging therapeutic appli-
cations. As vaccines, vectors derived from human adenovirus species D serotypes 26 and 48
(HAdV-D26/48) are demonstrating promising efﬁcacy as protective platforms against
infectious diseases. Signiﬁcant clinical progress has been made, yet deﬁnitive studies
underpinning mechanisms of entry, infection, and receptor usage are currently lacking. Here,
we perform structural and biological analysis of the receptor binding ﬁber-knob protein of
HAdV-D26/48, reporting crystal structures, and modelling putative interactions with two
previously suggested attachment receptors, CD46 and Coxsackie and Adenovirus Receptor
(CAR). We provide evidence of a low afﬁnity interaction with CAR, with modelling suggesting
afﬁnity is attenuated through extended, semi-ﬂexible loop structures, providing steric hin-
drance. Conversely, in silico and in vitro experiments are unable to provide evidence of
interaction between HAdV-D26/48 ﬁber-knob with CD46, or with Desmoglein 2. Our
ﬁndings provide insight into the cell-virus interactions of HAdV-D26/48, with important
implications for the design and engineering of optimised Ad-based therapeutics.
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Adenoviruses are increasingly important vectors for wide-ranging therapeutic interventions, from gene deliveryand oncolytic agents to platforms for vaccine applica-
tions1–3. As vaccine vectors, their use clinically has been
popularised by their excellent safety proﬁle coupled with their
ability to induce robust cellular and humoral immunogenicity
in humans4. Phylogenetically, the human adenoviruses
(HAdV’s) are diverse, subdivided across seven species, A–G5,
based classically on serological cross-reactivity, receptor usage,
haemagglutination properties and, more recently, phylogenetic
sequence similarity6,7.
Most experimental and clinical studies have focussed on the
well-studied species C adenovirus, HAdV-C5. Although
potently immunogenic, the efﬁcacy of vaccines based on HAdV-
C5 appears hampered by high seroprevalence rates in humans,
and enthusiasm for their use as clinical vaccine platforms has
been dampened by the well-publicised failure of the MERCK
sponsored STEP vaccine trial. This trial, to evaluate an HAdV-
C5-based HIV vaccine encoding HIV gag/pol/nef antigens, was
abandoned due to apparent lack of efﬁcacy upon 1st term
analysis. The study also identiﬁed a non-signiﬁcant trend
towards increased HIV acquisition in a speciﬁc high-risk,
uncircumcised subset of patients who also had high levels of
baseline pre-existing neutralising antibodies (NAbs) to HAdV-
C58,9. As a result, attention has switched from HAdV-C5-based
vectors towards the development of alternative adenoviral ser-
otypes with lower rates of pre-existing immunity. Most notably,
vectors under development include those based on species D
serotypes including HAdV-D26, which has entered Phase-III
clinical trials as an Ebola vaccine and recently reported pro-
mising immunogenicity in an HIV trial. Chimeric vectors uti-
lising the hexon hyper variable regions (HVRs) of HAdV-D48
which have undergone Phase-I evaluation as an HIV
vaccine3,10–12. However, despite extensive clinical advances
using these vaccine vectors we possess very limited knowledge
of their basic biology, particularly with regards to the deter-
minants underpinning their tropism, mechanisms of cellular
entry, and receptor usage. In this study, we address these
shortcomings through analysis of adenoviral diversity in the
context of their receptor binding, ﬁber proteins. Whilst ade-
noviruses are historically divided into seven species, A–G, this
may underestimate their diversity13–15. Phylogenetic examina-
tion of 56 human adenovirus ﬁber proteins from different
species shows deviation from the taxonomy expected based
upon whole genome taxonomy, likely due to recombination
events as seen in other adenoviral proteins14. Here, we have
sought to generate high-resolution crystallographic structures of
the cellular interacting ﬁber-knob domains of species D ade-
noviruses HAdV-D26 and HAdV-D48. The ﬁber-knob is the
receptor interacting domain of the ﬁber protein, one of three
major capsid proteins along with the hexon and penton base, as
shown schematically in Fig. 1a.
In this study, we employ an integrative workﬂow utilising X-ray
crystallography, in silico modelling, and in vitro assays to dissect
previous ﬁndings16,17 suggesting interactions by HAdV-D26 and
HAdV-D48 with Coxsackie and Adenovirus Receptor (CAR)5,18
and CD46 (Membrane Cofactor Protein, MCP)16,17,19–21. Utilis-
ing surface plasmon resonance (SPR), we also investigate the
potential for HAdV-D26 and HAdV-D48 to interact with Des-
moglein 2. Our ﬁndings shed new light on the cell–virus inter-
actions of adenovirus and have potential implications for
the design and engineering of optimised HAdV-based ther-
apeutics, both for vaccine applications and oncolytic develop-
ment, allowing us to minimise off-target or undesirable
interactions in vivo.
Results
Genetic variability in adenovirus ﬁber-knob protein. We gen-
erated phylogenetic trees of human adenovirus serotypes 1–56
which revealed greater diversity in the ﬁber-knob domain
(Fig. 1b) than might be expected based upon the taxonomy of the
whole virus (Fig. 1c). These phylogenetic trees have been con-
densed to 70% bootstrap conﬁdence (500 bootstrap replicates) to
exclude poorly supported nodes and display the projected
diversity. A full dendrogram showing to-scale branches is pro-
vided in Supplementary Figure 1. In both phylogenetic trees, the
adenoviruses divide into seven clades corresponding to the seven
adenoviral species, A–G. However, the tree based upon the ﬁber-
knob domain (Fig. 1b) shows the species D adenoviruses forming
a greater number of sub-groups than in the whole genome tree
suggesting greater diversity in the receptors of this species than
might be expected when comparing serotypes. This may be the
result of recombination events, as reported previously for other
adenoviral proteins13,15,22–24. The opposite is observed in species
B adenoviruses, where simpler groupings are seen when analysing
ﬁber-knob domain alignment than by whole genome analysis.
When divided into sub-species based on whole genome, they
divide into species B1 and B2, but when the tree is generated
based on ﬁber-knob alone the species B viruses do not divide into
similar groups. The signiﬁcance of this ﬁber-knob diversity is
unclear, but it has previously been suggested that the species B1/
B2 designation may more closely represent the tissue tropism,
than receptor usage25,26.
We next calculated the amino acid variability at each position
in the aligned adenoviral ﬁber-knob sequences, which revealed
regions of broad conservation corresponding to β-strands which
make up the main fold of the ﬁber-knob trimer (Fig. 1d). The
positions corresponding to the β-strands of HAdV-C5, as
originally reported by Xia et al.27, are shown by arrows.
Comparison shows that the more N-terminal (A, B, and C) and
C-terminal (I and J) β-strands have greater homology across the
adenoviral species than the other strands. This may relate to the
intervening loops between the less tightly conserved β-strands (D,
E, F, G, H) being more apical, a region which is often involved in
receptor interactions26,28–32.
Structural analysis of HAdV-D26 and HAdV-D48 ﬁber-knob.
To investigate diversity within the species D adenoviruses ﬁber-
knob protein, recombinant, 6-His-tagged ﬁber-knob protein from
HAdV-D26 and HAdV-D48 (hereafter referred to as HAdV-
D26K and HAdV-D48K) were generated, puriﬁed, and used to
determine X-ray crystallographic structures of HAdV-D26 (PDB:
6FJN) and HAdV-D48 (PDB: 6FJQ) at resolutions of 0.97 and
2.91 Å, respectively (Fig. 2a–d). Table 1 shows the data collection
and reﬁnement statistics for the crystallographic structures gen-
erated in this study.
The monomers (red, green, blue) form an anti-parallel β-
barrel, typical of adenoviral ﬁber-knob protein, as described by
Xia et al. (PDB 1KNB)27. Each monomer interacts with two
neighbouring copies to form a homotrimer with 3-fold symmetry
(Fig. 2b, d) and a highly stable interface (Supplementary
Figure 2A). Stability analysis using PISA (Protein Interactions,
Surfaces and Assemblies) software calculates the HAdV-D26 and
HAdV-D48 trimers to have >20% lower interface energy than
that of HAdV-C5, indicative of a more stable interaction
(Supplementary Figure 2A) between the monomers of the
HAdV-D26 and HAdV-D48 ﬁber-knobs.
As with the pan species analysis (Fig. 1d), variability of the
aligned species D ﬁber-knobs (Fig. 2e) conﬁrmed that the
β-strands comprising the hydrophobic core of the trimers are
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highly conserved, with β-strands demonstrating a high degree
of overlap in both spatial position and sequence variability
(Supplementary Figure 2B).
Fiber-knob loops are stabilised by inter-loop interactions.
Particularly relevant to this study are the DG, GH, HI, and IJ
loops, linking the indicated strands corresponding to those in the
originally reported HAdV-C5 ﬁber-knob loops (Supplementary
Figure 2B)27. These loops have previously been shown to be
critical in engagement of CD46 for Ad11, 35, and 2133–36.
Alignment of these loops with the corresponding loops of HAdV-
C5 (species C, CAR interacting), HAdV-B35 (species B, CD46
interacting), Ad11 (species B, CD46 interacting), and Ad37
(species D, CAR and Sialic acid/GD1a glycan interacting) reveals
different topologies in these critical receptor interacting regions
(Fig. 3a)35–38. The HI loops of HAdV-D26K and HAdV-D48K
are most homologous to those of HAdV-B35K and HAdV-D37K
respectively in terms of amino acid sequence identity (Supple-
mentary Figure 2B) and spatial alignment. The HAdV-D26K DG
loop is most homologous to HAdV-B35K but incorporates a
three amino acid insertion, while HAdV-D48K DG loop displays
a differing and unique topology. The GH and IJ loops of HAdV-
C5K, HAdV-D26K, HAdV-D37K, and HAdV-D48K demon-
strate similar spatial arrangements (though the similarity does not
extend to the sequence identity) but differ from the CD46 uti-
lising HAd-B11K and HAdV-B35K.
The high-resolution structures obtained allowed us to robustly
characterise the loops, seen in the electron density maps (Fig. 3b,
c). To assess loop ﬂexibility and mobility, we assessed the
B-factors (also known as temperature factor), a measure of the
conﬁdence in the position of an atom which can be used to infer
ﬂexibility. By assessing the B-factors, the relative ﬂexibility of the
moieties of interest can be inferred. While the apical domains of
some loops demonstrated increased B-factors relative to the rest
of the molecule, the loops’ B-factors are surprisingly low (Fig. 3b,
c), suggesting that they may exhibit limited ﬂexibility.
To investigate whether the different loop conformations were
the product of ﬂexibility, or restricted mobility we investigated
the inter-loop interactions in the HAdV-D26K and HAdV-D48K
structures. This analysis shows that the GH loop of HAdV-D26K
(like those of HAdV-C5K, HAdV-D37K, and HAdV-D48K) does
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Fig. 1 Phylogenetic analysis of adenoviruses mapped by whole genome and ﬁber-knob domain. A diagrammatic representation of the adenoviral major
capsid proteins shows the icosahedral capsid structure with the Hexon (orange) comprising the facets, pentons (green) at the vertices, from which the
ﬁber proteins (ﬁber-shaft in light blue, ﬁber-knob in dark blue) protrude (a). Condensed maximum likelihood trees (percentage conﬁdence shown by
numbers next to nodes) were generated from alignments of ﬁber-knob domain amino acid sequences of adenoviruses 1–56 (b) or whole genome NT
sequences (c). Adenoviruses divide into 7 subspecies, as denoted in the key, regardless of alignment used, but the species D adenoviruses divide into
additional sub-species when determined by ﬁber-knob alignment, for readability simple nomenclature is used, all are human adenovirus. Numbers next to
nodes denote conﬁdence. Wu–Kabat variability analysis of the Clustal Omega aligned ﬁber-knob domains amino acid sequences of adenoviruses 1–56
(d) reveals regions of low amino acid variability corresponding to beta-sheets. The locations of HAdV-C5 β-strands, as described by Xia et al. (1994)27, are
aligned to the structure and shown by arrows, the corresponding positions are coloured in red
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not extend directly away from the G and H β-sheets, but forms a
β-hairpin (Fig. 3a, b) that is maintained by seven polar contacts
within the neighbouring IJ loop which restrict the loops’
orientation (Fig. 4a, Supplementary Figure 3A). Polar contacts
were also observed at the apex of several loops, notably the GH
and CD loops (Fig. 4a, b). The IJ loops form fewer intramolecular
polar contacts but are stabilised by interactions with the adjacent
CD and DG loops (Supplementary Figure 3C, D). These
interactions retain the apical residues in a stable conformation,
rather than leaving the side chains fully labile.
The B-factors of the HAdV-D48K DG loop were observed to
be polarised about the hairpin, with the outer face of the loop
having higher B-factors compared to the inner face (Fig. 4c). This
is likely the result of polar contacts formed between Ser-307, Gln-
308, Ala-309, and Leu-304 with Asp-359 and Gln-357 of the
opposing monomer stabilising the conformation of the DG loop.
The proline-rich nature of this loop provides further rigidity
(Supplementary Figure 2D).
Crystal contacts did not reveal any speciﬁc interactions
between these DG-loops and neighbouring non-trimer copies.
We calculated the energy of interaction to be below the
background threshold (<−3.0 kcal mol−1) for all loops except
DG. The DG-loop of HAdV-D26K is calculated to have
interaction energy of −6.5 kcal mol−1 in two separate stretches
of this exceptionally long loop (Supplementary Figure 4).
Importantly, no strong contacts are found within the inter-
monomer cleft.
Based on this analysis of the inter and intra-loop bonds, we
suggest that these adenoviral loops may not be fully ﬂexible
variable regions, but organised receptor engagement motifs with
carefully evolved structures. This has direct implications for
receptor engagement of these viruses, as the loops govern
previously characterised interactions with CAR and CD46, and
are directly involved in their pathogenicity25,33,39.
In silico evaluation of HAdV-D26/48K interaction with CAR.
Both CD46 and CAR have been proposed as primary attachment
receptors for HAdV-D26 and HAdV-D4816,17. Previously gen-
erated crystal structures of HAdV-B11K in complex with full-
length CD46 (PDB: 3O8E), and HAd-D37K in complex with
CAR-D1 domain (PDB: 2J12) reveal the loops to be essential to
Trimer
side-on
Trimer
towards
virion
HAdV-D48 Fiber-Knob Domain (6FJQ)HAdV-D26 Fiber-Knob Domain (6FJN)
c
d
a
b
e
W
u-
Ka
ba
t
va
ria
bi
lity
 s
co
re
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200
40
A B C D E G H I J
35
30
25
20
15
10
5
0
X
Y Z
X
Y
Z
Fig. 2 Overview of the HAdV-D26 and HAdV-D48 ﬁber-knob protein structures. The surface representation of the trimeric HAdV-D26K (PDB 6FJN)
biological assembly is shown side-on with the cartoon representation shown for the nearest monomer (a) and the top-down view of the same HAdV-D26K
trimer, as it would appear looking towards the virion, is seen as a cartoon representation (b), with each monomer coloured in red, green, or blue with the
hypervariable loops extending between the β-strands (dark blue) coloured as follows: AB—green, BC—purple, CD—brown, DE—orange, DG—red, EG—
pink, GH—purple, HI—yellow, IJ—light blue. The HAdV-D48K (PDB 6FJQ) trimer is shown similarly (c, d). The Wu–Kabat variability plot of the ﬁber-knob
domains of species D adenoviruses shows regions of low variability (e) with the locations of the HAdV-D48K β-strands shown by arrows above the graph,
and the positions coloured blue, or red when the position is a β-strand in both HAdV-D26K and HAdV-D48K
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receptor interactions40. To investigate the ability of HAdV-D26K
and HAdV-D48K to bind these receptors we generated homology
models by alignment of the new HAdV-D26K and HAdV-D48K
ﬁber-knob structures modelled, using the existing ﬁber-knobs in
complex with the receptor of interest, and performed energy
minimisation to optimise the conformation to achieve the lowest
possible energy interface with which to analyse the interaction.
We performed similar experiments with the well-described CAR
and CD46 binding ﬁber-knob proteins of HAdV-C5 (PDB:
6HCN) and HAdV-B35 (PDB: 2QLK), respectively, as controls.
Modelling of HAdV-D26K and HAdV-D48K in complex with
the CAR-D1 domain revealed a region of high homology with the
CAR utilising HAdV-C5 ﬁber-knob, hereafter termed the α-
interface (Fig. 5a). Sequence alignment with HAdV-C5K shows
that many of the residues previously shown to be critical for CAR
interaction in HAdV-C5K are conserved in HAdV-D26K and
HAdV-D48K (Fig. 5b), including Ser-408, Pro-409, and Tyr-
37637. The same is true of residues predicted to interact with CAR
directly, such as Lys-417 (number is for HAdV-C5K). The
residues predicted to form direct CAR binding interactions for
HAdV-C5K, HAdV-D26K, and HAdV-D48K are pictured in
complex with the maximum spatial occupancy of the energy
minimised CAR-D1 (Fig. 5c). The high levels of homology are
seen to extend to the proteins’ fold as well as the linear sequence.
Binding energies were calculated between the modelled ﬁber-
knob proteins and CAR, restricting the calculation to only the α-
interface to best model the conserved region. For the modelled
complexes, a stable α-interface was predicted for all complexes
modelled, albeit weaker for the known non-CAR utilising HAdV-
B35K (Fig. 5d) which has lower sequence conservation with
HAdV-C5K. However, the interaction is complicated by a second
CAR interface, termed the β-interface (Fig. 6a). The loops
forming the β-interface with CAR-D1 differ between HAdV-C5,
HAdV-D26, and HAdV-D48 ﬁber-knob (Fig. 6b). The shorter
HAdV-C5K DG loop does not clash with the CAR-D1 surface,
whereas the extended HAdV-D26K DG loop forms a partial steric
clash, with surface seen to clash with the aligned CAR-D1, and
HAdV-D48K DG loop is seen to form an even larger steric clash.
Whilst the longer loop of HAdV-D26K is expected to be more
ﬂexible than that of HAdV-C5K, the HAdV-D48K DG loop is
surprisingly stable due to the characteristics described (Fig. 4c).
Biological evaluation of HAdV-D26/48K interaction with
CAR. Our modelling studies indicate that the longer, inﬂexible
DG loop of HAdV-D48K would be likely to sterically hinder the
HAdV-D48K: CAR interaction at the β-interface to a greater
extent than the more modest inhibition of the smaller and more
labile loop of HAdV-D26K, which in turn would exhibit more
inhibition of CAR binding than that of HAdV-C5K, where no
steric inhibition is observed. Competition inhibition assays using
recombinant ﬁber-knob protein to inhibit antibody binding to
CAR receptor in CHO-CAR cells (which express CAR, while the
parental cell line (CHO-K1) is established to be non-permissive to
adenovirus infection) support our observations (Fig. 6c). The IC50
(the concentration of protein required to inhibit 50% of antibody
binding) of HAdV-C5K is 7.0 ng/105 cells, while HAdV-D26K
and HAdV-D48K demonstrate IC50 values 15.7 and 480 times
higher at 0.110 μg/105 cells and 3.359 μg/105 cells, respectively,
reﬂecting their reduced ability to engage CAR.
SPR analysis indicates that HAdV-C5K binds strongly to CAR
(Fig. 6d) with a KD of 0.76 nM. HAdV-D26K and HAdV-D48K
have lower overall afﬁnities for CAR (Fig. 6e). While the KOff of
the three ﬁber knob proteins (Fig. 6e) are similar, the KOn is
fastest for HAdV-C5K, with HAdV-D26K KOn being slower, and
HAdV-D48K exhibiting the slowest KOn. This shows that the
KOn—the ability to form the initial interaction with the receptor
—is the major limiting factor in the ﬁber knobs overall afﬁnity for
CAR.
In silico evaluation of HAdV-D26/48K interaction with CD46.
A similar approach was taken to model HAdV-D26K and HAdV-
D48K in complex with CD46. Alignments with the previously
published HAdV-B11K-CD46 complex were generated and
energy minimised to obtain the lowest energy state of the
complex34,41. This interface utilises loops DG, GH, HI, and IJ to
form a network of polar interactions with the CD46 Sc1 and Sc2
domains (Fig. 7a)35.
When HAdV-B35K was modelled in complex with CD46, a
network of polar contacts between HAdV-B35K and CD46 was
predicted (Fig. 7b) similar to that observed in the HAdV-B11K-
CD46 complex crystal structure, PDB: 3O8E (Fig. 7a)34.
Previously, HAdV-B35K residues Phe-243, Arg-244, Tyr-260,
Arg-279, Ser-282, and Glu-302 (underlined in Fig. 7c) have been
implicated as key contact residues for CD46 interaction, and are
conserved in HAdV-B11K (highlighted in blue, Fig. 7c)36. Our
modelling suggests that conversely, HAdV-D26K and HAdV-
D48K are predicted to form very few polar contacts with CD46
with just two contacts predicted for HAdV-D26K (Fig. 7d) and
three predicted for HAdV-D48K (Fig. 7e). Furthermore, they do
not share any of the critical CD46 binding residues which have
been reported previously (underlined, Fig. 7c) for HAdV-B11K
and HAdV-B35K, or any of the predicted interacting residues
(blue highlight, Fig. 7c).
We again employed PISA to calculate the binding energy of the
various modelled and energy minimised ﬁber-knob CD46
complexes (Fig. 8a). HAdV-B11K, the strongest known CD46
binding adenovirus33, was predicted to have the lowest binding
Table 1 Data collection and reﬁnement statistics (molecular
replacement)
HAdV-D26K HAdV-C5K HAdV-D48K
Data collection
Space group P 213 P 21212 P 4332
Cell dimensions
a, b, c (Å) 86.01, 86.01,
86.01
102.16, 102.44,
77.01
145.18, 145.18,
145.18
α, β, γ (°) 90.0, 90.0,
90.0
90.0, 90.0,
90.0
90.0, 90.0,
90.0
Resolution (Å) 0.97–60.82
(0.97–1.00)
1.49–61.56
(1.49–1.53)
2.91–83.82
(2.91–2.99)
Rsym or Rmerge 0.043 (0.745) 0.134 (1.838) 0.125 (302.6)
I/σI 27.3 (0.7) 7.1 (0.7) 22.2 (1.7)
Completeness (%) 94.9 (43.9) 99.8 (99.9) 100.0 (100)
Redundancy 16.7 (1.6) 6.6 (6.3) 41.2 (41.4)
Reﬁnement
Resolution (Å) 0.97–60.82 1.49–61.56 2.91–83.82
No. reﬂections 112,612 125,479 11,371
Rwork/Rfree 18.2/19.5 21.1/23.3 20.1/29.1
No. atoms 1811 4825 3117
Protein 1579 4395 3091
Ligand/ion 8 21 20
Water 224 409 6
B-factors 16.0 34.0 87.0
Protein 15.8 33.6 94.2
Ligand/ion 29.3 35.7 129.5
Water 23.9 42.9 61.0
R.M.S. deviations
Bond lengths (Å) 0.025 0.011 0.019
Bond angles (°) 2.339 1.534 2.293
One crystal was used for each dataset
Values in parentheses are for highest-resolution shell
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energy reﬂecting its high stability interface, with HAdV-B35
demonstrating a similar but slightly reduced binding energy.
Conversely, HAdV-D26K and HAdV-D48K are predicted to have
lower binding energies, similar to that which may be expected for
random proteins passing in solution, indicating that any
interaction between either the HAdV-D26K, or HAdV-D48K
with CD46 is unlikely42.
While still low compared to the known CD46 interacting
HAdV-B11K and HAdV-B35K binding energies, that for HAdV-
C5K was higher than expected for a known non-CD46 interacting
adenovirus (Fig. 8a). Inspection of the model shows that this is
due to the close proximity of the large HAdV-C5 HI loop to
CD46 (Fig. 8b). The residues involved in the predicted interaction
are not conserved in any known CD46 interface and suggesting
these are random interactions. Furthermore, interaction between
the DG loop and CD46 is integral to known CD46 binding
interfaces and is prevented by the HAdV-C5K HI loop laying
between them (Fig. 8b).
Biological evaluation of HAdV-D26/48K interaction with
CD46. Antibody competition inhibition assays in CHO-BC1 cells
(CHO cells transduced to express the BC1 isoform of CD46) were
used to test the predictions made by modelling (Fig. 8c). These
data conﬁrm that recombinant HAdV-D26K and HAdV-D48K
proteins are incapable of inhibiting antibody binding to CD46 at
any concentration tested (up to 2 ng/cell), whilst the well-deﬁned
CD46 interacting HAdV-B35K demonstrates strong inhibition,
with a calculated IC50 of 0.003 μg/105 cells.
SPR analysis of the interaction between recombinant ﬁber-
knob protein with CD46 conﬁrms these ﬁndings. The known
CD46 utilising HAdV-B35K is seen to bind CD46 even at low
concentration, while HAdV-D48K shows no interaction (Fig. 8d).
HAdV-D26K shows a very low afﬁnity interaction with CD46,
however the kinetics are extremely fast making it impossible to
measure an accurate KOn/Off at any of the concentrations
measured, suggesting an unstable interface. The calculated KD
for HAdV-D26K is seen to be more than 1.5 × 103 times lower
than that of HAdV-B35K (Fig. 8e).
In silico evaluation of HAdV-D26/48K interaction with DSG-
2. The third major protein receptor for human adenoviruses is
Desmoglein 2 (DSG2), shown to enable infection by HAdV-B3,
B7, B11, and B1443,44. Whilst we have not been able to model the
interaction of HAdV-D26 or D48 with DSG2, due to the lack of
an available high-resolution complexed structure at the time of
writing, we investigated the interaction by SPR analysis. HAdV-
B3 is the best studied DSG2 binding adenovirus and showed
binding in the μM range when tested by SPR (Fig. 9a), however,
no binding was observed when the same experiment was run with
HAdV-D26K or HAdV-D48K (Fig. 9b).
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Fig. 3 Comparison of HI, DG, GH, and IJ loops of adenoviruses used in this study. a The hypervariable loops of HAdV-D26K (green) and HAdV-D48K
(cyan) relevant to this study (HI, DG, GH, and IJ) are shown in the context of the control virus ﬁber-knob domains, HAdV-C5K (orange), Ad11K (yellow),
HAdV-B35K (pink), and Ad37K (purple). The electron density achieved in the loops of HAdV-D26K (b) and HAdV-D48K (c) are shown as mesh. The
ﬁtted residues are seen as stick representations, with oxygen and nitrogen atoms coloured red and blue, respectively and other atoms coloured according
to their relative B-factors with warmer colours indicating higher B-factor values
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Discussion
This study reveals the crystal structure of two adenovirus proteins
critical to primary receptor engagement, HAdV-D26 and HAdV-
D48 ﬁber-knob, which are important viral vectors currently in
human clinical trials3,11,12. Despite their advanced development,
the ﬁeld lacks fundamental knowledge regarding the mechanisms
of infection for these viral vector platforms. The work we
described here provides a combined crystallographic, in silico,
and in vitro approach to investigate adenovirus ﬁber-knob:
receptor interactions with CAR and CD46, two receptors pre-
viously proposed to be utilised by these viruses5,9,17.
Analysis of the phylogenetic relationship between 56 adeno-
virus serotypes, by both whole genome and ﬁber-knob domain
alignment (Fig. 1a), conﬁrms diversiﬁcation into the widely
accepted seven adenoviral species7. However, generating the
phylogenetic tree with ﬁber-knob sequences, rather than whole
genomes, shows additional diversity, not revealed by the whole
virus taxonomy. Adenovirus species D breaks up into several
additional sub-clades when focused on the ﬁber-knob, suggesting
greater receptor diversity than might be expected based on the
whole virus phylogeny. Similar observations have previously been
made in species D hexon and penton13.
In contrast to species D, the phylogeny of species B adeno-
viruses, which are known to utilise Desmoglein 2 and CD46 as
primary receptors, is simpliﬁed when focused upon the ﬁber-
knob, indicating less diverse receptor usage39,43–45. This simpli-
ﬁcation in comparison to the whole genomic alignment implies
that much of the species diversity must lay in other proteins. The
E3 protein, for example, is known to be highly diverse within
species B adenoviruses, having previously been exploited in the
selection of the oncolytic (cancer killing) virus enadenotucirev,
which is currently in clinical trials13,46,47.
That we see such opposing effects on the species B and D
phylogenetic trees when focusing on the ﬁber-knob, highlights
the limitations of simple taxonomic approaches. The current
adenoviral taxonomy is based on antibody neutralisation
assays, which are limited by antibody's reliance on surface
accessible proteins in the capsid, and does not account for
diversity in other viral proteins, as the above suggests for spe-
cies B. This supports a taxonomic proposal based upon viral
genetics rather than antibody neutralisation, as has previously
been suggested13,48.
Many studies on adenovirus neutralisation have focused upon
NAbs which bind to the hexon49–51. Following intramuscular
vaccination with non-replicating adenoviral vectors, most NAbs
are targeted to the hexon; a reﬂection of its high abundance and
surface availability in each viral capsid49,52. However, during
natural infection, many NAbs target the ﬁber protein52, pre-
sumably due to the abundance of ﬁber produced in the early
stages of hAdV replication to loosen cell–cell junctions and
facilitate viral spread, prior to lysis and entry of large amounts of
whole virus to the bloodstream53. For individuals with pre-
existing anti-adenovirus immunity derived from natural infec-
tions, anti-ﬁber NAbs are likely to limit the use of vectors with
common adenovirus ﬁber proteins by neutralisation of the viral
vector prior to its therapeutic effect. Thus, for the development of
vectors to circumvent pre-existing anti-adenovirus immunity for
therapeutic use further exploration of this ﬁber protein diversity
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may be beneﬁcial, as well as the on-going studies using hexon
HVR pseudotypes to circumvent anti-hexon immunity11,54.
Analysis of the adenovirus loops (Fig. 4, Supplementary Fig-
ure 3) reveals an intricate network of polar interactions which
stabilise their three-dimensional structures. These bonds appear
to hold the loops in a conformation which, in the case of HAdV-
B11K and HAdV-B35K, facilitates receptor binding. In the
HAdV-D26 and HAdV-D48 ﬁber-knob structures presented in
this study the loops are also held in a stable conformation, though
not one which enables CD46 interaction.
Modelling of HAdV-D26K/HAdV-D48K in complex with
CD46 (Fig. 7) suggested few contacts, and interface energy cal-
culations using these models predict a weak binding energy
(Fig. 8). SPR indicated that HAdV-D26K has an afﬁnity for CD46
that is approximately 1500× weaker than that of HAdV-B35K
(Fig. 8d, e). Combined with the extremely fast kinetics, this is
suggestive of a highly unstable interface. HAdV-D48K showed no
afﬁnity for CD46 at all. This was conﬁrmed by in vitro compe-
tition inhibition assays, in which no tested quantity of recombi-
nant ﬁber-knob was capable of inhibiting antibody binding to
CD46 (Fig. 8c). These ﬁndings appear contradictory to previous
studies which suggest CD46 as the primary receptor for these
viruses16,17. Our ﬁndings improve knowledge of the cell entry
mechanisms of these viruses and the vectors derived from them,
and do not diminish the observed effectiveness of these vaccines.
However, if CD46, a protein expressed on the surface of all
nucleated cells, is not the receptor for these viruses then it is as yet
unknown what the primary tissue tropism determinant is for
these clinically signiﬁcant viruses55,56.
A similar methodology was applied to the interaction HAdV-
D26K/HAdV-D48K with CAR. Inspection of the modelled
complexes (Fig. 5) indicated a conserved α-interface enabling
CAR binding in adenovirus 5, 26, and 48, ﬁber knobs. However,
the structure of the β-interface interaction appears to indicate a
mechanism modulating the ﬁber-knob’s CAR afﬁnity (Fig. 6).
When occupying the intermonomer cleft in the conformation
shown in Fig. 6b, the DG loops of HAdV-D26K and HAdV-
D48K are likely to inhibit CAR binding by steric hindrance, but if
the loops were to shift into a conformation which relieves this
clash CAR binding could occur. Therefore, the ability of these
vectors to interact with CAR is likely a function of the steric
hindrance provided by these loops, reducing the ability of the
ﬁber-knob domain to engage CAR in a permissive conformation.
SPR analysis supports this hypothesis (Fig. 6d, e), where the larger
the DG loop of the investigated ﬁber-knob the slower the KOn.
The inter-loop contacts described in Fig. 4a, b, and Supple-
mentary Figure 3, and the normalised B-factors described in
Fig. 6b will inﬂuence the molecular dynamics of the DG-loops.
a b
HAdV-C5K
HAdV-B35K
HAdV-D37K
HAdV-D26K
HAdV-D48K
396
129
180
184
178
HAdV-C5K
HAdV-B35K
HAdV-D37K
HAdV-D26K
HAdV-D48K
467
204
255
256
255
HAdV-C5K
HAdV-B35K
HAdV-D37K
HAdV-D26K
HAdV-D48K
533
273
323
326
332
c
α
0
–5
–10
–15
Ad37K Ad5K Ad35K Ad26K Ad48K
d
kc
al
 m
ol
–
1
Fig. 5Modelling of the HAdV-D26K and HAdV-D48K interaction with CAR at the α-interface. The α-interface region is shown by the box on the structural
alignment of HAdV-C5K (orange), 26K (green), and 48K (cyan) ﬁber-knob domain crystal structures in complex with CAR-D1 domain (grey) as
determined by homology alignment to the previously reported Ad37K CAR-D1 structure (PDB: 2J12) (a). The aligned amino acid sequence of the
investigated ﬁber-knobs (b) and the predicted α-interface forming CAR-D1 binding residues are highlighted in blue, with the underlined residues
representing the HAdV-C5K amino acids shown by Kirby et al. (2000)37 to be important for CAR interaction. Conservation of key residues can be seen
between HAdV-C5K, HAdV-D26K, and HAdV-D48K ﬁber-knobs. This conservation is visualised, with the contact residues comprising the α-interface with
HAdV-C5K, 26K, and 48K shown as sticks in complex with the energy minimised CAR-D1 domain (grey), shown as the surface of the maximum spatial
occupancy of the aligned CAR-D1 monomers from each of the energy minimised models in complex with HAdV-C5K, 26K, and 48K ﬁber-knobs (c). d Plots
the predicted binding energy of the energy minimised ﬁber-knob proteins to CAR-D1 complex in the α-interface, only. Lower binding energy indicates a
more stable interface with the red line depicting 3.0 kcal mol−1, which can be considered background. n= 3, where each calculation is an independent ﬁber-
knob: CAR interface, error bars indicate mean ± SD
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Loops which can occupy a CAR inhibitory conformation but have
fewer stabilising contacts, such as that of HAdV-D26K (Supple-
mentary Figure 3A, C), should be more permissive to CAR
binding. While loops which are less ﬂexible and/or stabilised in a
CAR inhibitory conformation, such as HAdV-D48K (Fig. 6b,
Supplementary Figure 3B, D) should result in a ﬁber-knob which
is less able to bind CAR. This hypothesis ﬁts the competition
inhibition studies shown in Fig. 6c, which demonstrate that
HAdV-D26K has an approximately ~15× lower afﬁnity for CAR
than HAdV-C5K, and HAdV-D48K has 500× lower afﬁnity.
Interestingly, the afﬁnity of HAdV-D48K for CAR as measured
by SPR is approximately 2× higher than that for HAdV-D26K,
due to the slower KOff of HAdV-D48K (Fig. 6e) which is in
contrast with the IC50 curves (Fig. 6c) in which HAdV-D48K is
observed to bind to CAR less strongly than HAdV-D26K. The
incongruity may be explained by the methodology. It is possible
that the large ﬂuid volume in the wells during the inhibition assay
(in comparison to the BIAcore microﬂuidics system), favoured
greater binding by HAdV-D26K due to its faster KOn, compared
to HAdV-D48K. This discrepancy does not alter the proposed
model of CAR interaction, and seems to conﬁrm the importance
of the KOn, presumably mediated by the β-interface.
Species D adenoviruses have a large range of different DG
loops (Supplementary Figure 5). Most sequences have lengths
equal to, or greater than, that of HAdV-D26K, making it plausible
that they too could modulate the ﬁber-knob interaction with
CAR. However, the magnitude of this effect will be dependent on
the individual molecular dynamics of the DG-loops and its
interactions with adjacent residues.
Assuming this mechanism of CAR binding regulation is
broadly applicable, it may have important implications for ade-
noviral vector design. The presence of a high afﬁnity receptor for
the virus can mask the low afﬁnity CAR interaction, creating a
hidden tropism only observed if the virus is forced to rely upon it.
Expression of CAR on human erythrocytes suggests the potential
for sequestration of virotherapies in the blood57. CAR expression
in lung epithelial tissues offers another site for potential off target
activity58,59. Therefore, many virotherapies previously thought to
be non-CAR binding adenoviruses may in fact demonstrate weak
CAR tropism, driving off target infections or resulting in
1000
800
400
200
0
–200
c
2.6
3.2
1.6
ba
β
IC50= 0.007 µg/10
5
 cells
IC50= 0.110 µg/10
5
 cells
IC50= 3.359 µg/10
5
 cells
Kon (M–1 s–1) Koff (s–1) KD (µM)
HAdV-C5K 2×106 0.0016 0.00076
HAdV-D26K 3.4×102 0.0074 21
HAdV-D48K 2.5×102 0.0024 9.3
0 200 400 600 800 1000 1200
0 200 400 600 800 1000 1200
0 200 400 600 800 10001200
600
300
0
d
e
HAdV-C5K
HAdV-D26K
HAdV-D48K
Fiber-knob concentration (µg/105 cells)
N
or
m
al
is
ed
 to
ta
l f
lu
or
es
ce
nc
e 
in
Al
ex
a 
64
7 
po
sit
ive
 C
HO
-C
AR
 c
el
ls
10–5 10–4 10–3 10–2 10–1 100 101 102 103
0
25
50
75
100
125
1000
800
400
200
0
–200
Fig. 6Modelling of the HAdV-D26K and HAdV-D48K interaction with CAR at the β-interface. The β-interface region is shown by the box on the structural
alignment of HAdV-C5K (orange), 26K (green), and 48K (cyan) ﬁber-knob domain crystal structures in complex with CAR-D1 domain (grey) as
determined by homology alignment to the previously reported Ad37K CAR-D1 structure (PDB: 2J12) (a). A dot surface shows the surface of HAdV-C5K,
26K, and 48K DG-loops in the inter-monomer cleft (b). The boxes denote the maximum B-factor of the corresponding loops, which are shown as putty
representations with thicker regions indicating higher relative B-factors, from which we can infer the relative stability of the loops. Antibody competition
inhibition assay (c) shows the relative inhibitory ability of the HAdV-C5, 35, 26, and 48, ﬁber-knob domains in CAR expressing CHO-CAR cells, with the
calculated IC50 values shown in boxes. n= 3 biological replicates. Surface plasmon resonance (SPR) traces are shown by coloured lines, and the ﬁtted
curves by black lines (d). The calculated binding coefﬁcients on rate (KOn), off rate (KOff), and dissociation coefﬁcient (KD) are given in the table (e). IC50
curves are ﬁtted by non-linear regression. Error bars represent standard deviation of 3 biological replicates. Error bars indicate mean ± SD
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sequestration of the vector in tissues other than that target. This
may not be of grave consequence for non-replicating vectors,
such as viral vaccines, but in vectors which rely upon controlled
replication in targeted tissues, such as oncolytic virotherapies, this
could result in off-target infection, dysregulated expression of
therapeutic protein, and reduced delivery to the point of need.
DSG2 was also shown to be unable to bind HAdV-D26K or
HAdV-D48K at any concentration by SPR. It is notable that the
KD measured for the HAdV-B3K (66.9 μM) is much lower than
that measured during the original investigation of DSG2 as an
HAdV-B3K receptor (2.3 nM)44. This is likely due to our use of
recombinant knob trimers, rather than the multivalent penton
dodecahedrons.
The ﬁnal, known, adenovirus ﬁber-knob receptor, which has thus
far not been addressed in this study is sialic acid, as part of gly-
cosylation motifs. Several adenoviruses have been shown to bind to
sialylated glycans, including HAdV-D3732,38, HAdV-G5230,60, and
Canine adenovirus serotype 2 (CAdV-2)57. Each of these three
viruses binds to sialic acid by different mechanisms (Supplementary
Figure 6). Supplementary Figure 6 shows that HAdV-D26/48K do
not share the sialic acid binding residues found in HAdV-G52K or
CAV-2 but do share the Tyr-142 and Lys-178 contact residues with
HAdV-D37K. Further, the HAdV-D37K contact residue Pro-147 is
between the sialic acid and the main chain oxygen which is func-
tionally identical at the similar position in HAdV-D26/48K. Taken
together, it remains plausible that HAdV-D26/48K may be capable
of binding sialic acid in an HAdV-D37K-like manner. However,
binding does not equate to functional infection, as seen with
HAdV-D19pK32 and further studies are required to ascertain
whether HAdV-D26/48 are capable of utilising sialic acid to gen-
erate a productive infection. Further, HAdV-D37 was shown to
require a speciﬁc glycosylation motif (GD1a) in order form a
functional infection, so any assessment of sialic acid as an adeno-
viral receptor must be in the context of its glycan carrier38.
The work undertaken in this study presents, for the ﬁrst time,
the crystal structures of the ﬁber-knob domain protein of HAdV-
D26 (PDB: 6FJN), and HAdV-D48 (PDB: 6FJQ) ﬁber-knob
protein. In addition, we report a new crystal structure for HAdV-
C5 ﬁber-knob protein (PDB: 6HCN) with improved resolution
compared to the existing structure (PDB: 1KNB)27. We utilised
these structures to investigate the ability of these proteins to
interact with the putative receptors, CAR and CD46, by an
integrative structural, in silico, and in vitro workﬂow. We
demonstrate that HAdV-D26 and HAdV-D48 ﬁber-knob
domains have a weak ability to bind CAR, and negligible CD46
interaction, suggesting that these viruses are unlikely to utilise
these proteins as a primary receptor in vivo. Finally, we showed
that DSG2 is also unable to form a stable interaction in the
context of SPR analysis. We suggest that CAR binding is mod-
erated by a previously unreported mechanism of steric inhibition
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Fig. 7Modelling of the HAdV-D26K and HAdV-D48K with CD46. Red dashes show contacts between the energy minimised crystal structure of CD46 SC1
and SC2 domains (grey cartoon) and Ad11K in complex (PDB 3O8E) (a). The known CD46 interacting ﬁber-knob, HAdV-B35K (purple), is aligned to the
above crystal structure and energy minimised (b). Amino acid sequence alignment of the tested ﬁber-knob proteins (c) shows conservation of residues
previously shown by Wang et al. (2007)36 to be key to CD46 binding (underlined) between the known CD46 binding ﬁber-knobs, Ad11K and HAdV-B35K.
Residues highlighted in blue are predicted to form direct contacts with CD46 in the energy minimised models. Similar alignments to that performed with
HAdV-B35K are shown for HAdV-D26K (Green—d) and HAdV-D48K (cyan—e). In all models, red dashes indicate polar contacts between the residues
shown as stick representations
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Fig. 9 Desmoglein 2 is unlikely to be a receptor for HAdV-D26K or HAdV-D48K. The dissociation constant was calculated for HAdV-B3K binding to DSG2,
but kinetics were too fast to determine KOn or KOff (a), the KD curve is shown for HAdV-B3K while HAdV-D26K and HAdV-D48K are seen to form no
interaction with DSG2 (b). nm (not measured) indicates that the kinetics were too fast to measure, nb denotes no binding
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Fig. 8 Binding energetics and afﬁnities of HAdV-D26K and HAdV-D48K with CD46. Calculation of the predicted binding energies for the energy minimised
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by coloured lines, and the ﬁtted curves by black lines (d). The calculated binding coefﬁcients on rate (KOn), off rate (KOff), and dissociation coefﬁcient (KD)
are given in the table (e), nm (not measured) indicates that the kinetics were too fast to measure, nb denotes no binding. IC50 curves are ﬁtted by non-
linear regression. Error bars represent standard deviation of 3 biological replicates. Error bars indicate mean ± SD
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which may apply to other adenoviruses and demonstrate an in
silico methodology capable of rapidly predicting these interac-
tions. These ﬁndings enhance our understanding of the virology
of adenovirus infection, and have direct implications for vir-
otherapy vector design, which often rely upon carefully controlled
receptor tropisms to achieve speciﬁcity and efﬁcacy9,18,28.
Methods
Genome alignment and analysis of genetic diversity. Representative whole
genomes (nucleotide) of adenoviral species 1–56 were selected from the National
Center for Biotechnology Information (NCBI), and aligned using the EMBL-EBI
Clustal Omega tool61,62. Fiber-knob domain amino acid sequences were derived
from the same genome sequences, deﬁned as the translated nucleotide sequence of
the ﬁber protein (pIV) from the conserved TLW hinge motif to the protein C-
terminus, and aligned in the same manner as the whole genomes. Phylogenetic
relationships were inferred using the maximum likelihood method based upon the
Jukes Cantor model for the whole genome nucleotide analysis63, and the Poisson
correction model for the ﬁber-knob amino acid analysis64, using MEGA X soft-
ware65. Conﬁdence was determined by bootstrap analysis (500 replicates)66 and
trees displayed condensed at 70% conﬁdence (percentage conﬁdence values shown
at each node) where stated.
Fiber-knob amino acid variability. Amino acid sequence variability scores were
calculated from the Clustal Omega aligned amino acid sequences of the ﬁber-knob
domains of either adenoviruses 1–56, or only the species D adenoviruses. Analysis
was performed using the Protein Variability Server (PVS), using a consensus base
sequence and the Wu–Kabat method67.
Generation of recombinant ﬁber-knob protein. SG13009 Escherichia coli har
bouring pREP-4 plasmid and pQE-30 expression vector containing the ﬁber-knob
DNA sequence were cultured in 20ml LB broth with 100 μg/ml ampicillin and
50 μg/ml kanamycin overnight from glycerol stocks made in previous studies18,68,69.
1 L of TB (Terriﬁc Broth, modiﬁed, Sigma-Aldrich) containing 100 μg/ml ampicillin
and 50 μg/ml were inoculated with the overnight E. coli culture and incubated at
37 °C until they reached OD0.6. IPTG was then added to a ﬁnal concentration of
0.5mM and the culture incubated at 37 °C for 4 h. Cells were then harvested by
centrifugation at 3000g, resuspended in lysis buffer (50mM Tris, pH 8.0, 300mM
NaCl, 1% (v/v) NP40, 1 mg/ml Lysozyme, 1 mM β-mercaptoethanol), and incu-
bated at room temperature for 30min. Lysate was clariﬁed by centrifugation at
30,000g for 30min and ﬁltered through a 0.22 μm syringe ﬁlter (Millipore,
Abingdon, UK). Clariﬁed lysate was then loaded onto a 5 ml HisTrap FF nickel
afﬁnity chromatography column (GE) at 2.0 ml/min and washed with 5 column
volumes into elution buffer A (50mM Tris [pH 8.0], 300mM NaCl, 1 mM
β-mercaptoethanol). Protein was eluted by 30min gradient elution from buffer A to
B (buffer A+ 400mM Imidazole). Fractions were analysed by reducing SDS-PAGE,
and ﬁber-knob containing fractions further puriﬁed using a superdex 200
10/300 size exclusion chromatography column (GE) in crystallisation buffer
(10mM Tris [pH 8.0] and 30 mM NaCl). Fractions were analysed by SDS-PAGE
and pure fractions concentrated by centrifugation in Vivaspin 10,000 MWCO
(Sartorius, Goettingen, Germany) proceeding crystallisation.
Competition inhibition assays. CHO cells expressing the appropriate receptor
(CAR: CHO-CAR, or CD46: CHO-BC1) were seeded at a density of 30,000 cells
per well in a ﬂat bottomed 96-well tissue culture plate and incubated at 37 °C
overnight. Serial dilutions were made up in serum-free RPMI-1640 to give a ﬁnal
concentration range of 0.0001–100 μg/105 cells of recombinant soluble knob pro-
tein. Cells were incubated on ice for 30 min, then washed twice with cold PBS.
Fiber-knob dilutions were then added to the cells and incubated on ice for 30 min.
Cells were then washed twice in cold PBS and stained with the primary CAR or
CD46 antibody, RmcB (Millipore; 05-644) or MEM-258 (Abcam; Ab789),
respectively, to complex receptors unbound by ﬁber-knob protein, and incubated
for 1 h on ice. Cells were washed twice further in PBS and incubated on ice for 1 h
with Alexa-647 labelled goat anti-mouse F(ab’)2 (ThermoFisher; A-21237)18,68,69.
All antibodies were used at a concentration of 2 μg/ml.
Samples were run in triplicate and analysed by ﬂow cytometry on Attune NxT
(ThermoFisher), and analysed using FlowJo v10 (FlowJo, LLC) by gating
sequentially on singlets, cell population, and Alexa-647 positive cells. Total
ﬂuorescence (TF) was used as the measure of inhibition, rather than percentage of
ﬂuorescent cells in the total population, to account for the presence of multiple
receptor copies per cell surface which can enable partial inhibition of antibody
binding on the cell surface. TF was deﬁned as the percentage of Alexa-647 positive
cells in the single cell population for each sample and multiplied by the median
ﬂuorescent intensity (MFI) of the Alexa-647 positive single cell population in each
sample. Data points are the mean total ﬂuorescence of three biological replicates
with error given as the standard deviation from the mean. IC50 curves were ﬁtted
by non-linear regression, and used to determine the IC50 concentrations18,68,69.
CHO-CAR and CHO-BC1 cells were originally derived by Bergelson et al.70 and
Manchester et al.71, respectively.
Crystallisation and structure determination. Protein samples were puriﬁed into
crystallisation buffer (10 mM Tris [pH 8.0] and 30 mM NaCl). The ﬁnal protein
concentration was approximately 7.5 mg/ml. Commercial crystallisation screen
solutions were dispensed into 96-well plates using an Art-Robbins Instruments
Griffon dispensing robot (Alpha Biotech, Ltd.), in sitting-drop vapour-diffusion
format. Drops containing 200 nl of screen solution and 200 nl of protein solution
were equilibrated against a reservoir of 60 μl crystallisation solution. The plates
were sealed and incubated at 18 °C.
Crystals of HAdV-C5K appeared in PACT Premier condition D04 (0.1 M
MMT, pH 7.0, 20% PEG 1500), within 1–7 days. Crystals of HAdV-D26K appeared
within 1–7 days, in PACT Premier (Molecular Dimensions, Suffolk, UK) condition
A04; 0.1 M MMT [DL-malic acid, MES monohydrate, Tris], pH 6.0, 25% PEG
1500. Crystals of HAdV-D48K appeared in PACT Premier condition D02 (0.1 M
Bis–Tris-propane, pH 6.5, 20% PEG 3350, 0.2 M NaNO3), within 2 weeks. Crystals
were cryoprotected with reservoir solution to which ethylene glycol was added at a
ﬁnal concentration of 25%. Crystals were harvested in thin plastic loops and stored
in liquid nitrogen for transfer to the synchrotron. Data were collected at Diamond
Light Source beamline I04, running at a wavelength of 0.9795 Å. During data
collection, crystals were maintained in a cold air stream at 100 K. Dectris Pilatus
6M detectors recorded the diffraction patterns, which were analysed and reduced
with XDS, Xia272, DIALS, and Autoproc73. Scaling and merging data was
completed with Pointless, Aimless and Truncate from the CCP4 package74.
Structures were solved with PHASER75, COOT76 was used to correct the sequences
and adjust the models, REFMAC577 was used to reﬁne the structures and calculate
maps. Graphical representations were prepared with PyMOL78. Reﬂection data and
ﬁnal models were deposited in the PDB database with accession codes: HAdV-
C5K, 6HCN; HAdV-D26k, 6FJN; and HAdV-D48k, 6JFQ. Full crystallographic
reﬁnement statistics are given in Supplementary Table 2; stereo images depicting
representative areas of the model and map are provided in Supplementary Figure 7.
Modelling of ﬁber-knob ligand interactions. Fiber-knob proteins were modelled
in complex with CAR or CD46 using the existing HAdV-D37K—CAR liganded
(PDB 2J12) or the HAdV-B11K—CD46 liganded (PDB 3O8E) structures, respec-
tively, as a template. Non-protein components and hydrogens were removed from
the template model and the ﬁber-knob protein of interest. The two ﬁber-knob
proteins were then aligned with respect to their Cα chains, in such a way as to
achieve the lowest possible RMSD. Models containing only the ﬁber-knob protein
of interest and the ligand were saved and subjected to energy minimisation, using
the YASARA self-parametrising energy minimisation algorithm as performed by
the YASARA energy minimisation server, and results were visualised in PyMol78,79.
Calculation of interface energy. Interface energies were calculated using QT-
PISA using biological protein assemblies and excluding crystallographic inter-
faces80. Values are the mean of the three symmetrical interfaces in each trimer and
error is the standard deviation from the mean, any values above −3.0 kcal mol−1
were considered to be background as shown as a red dashed line on graphs42.
Sequence alignments. Alignments were performed using the Clustal Omega
multiple sequence alignment algorithm and visualised with BioEdit61,62.
B-factor normalisation. Comparing order between different structures by com-
paring individual B-factors can be misleading. Post-reﬁnement B-factors relate to
the Wilson B-factor, which can vary widely between data sets, even from the same
crystal preparation. A valid comparison between different structures can be
achieved by comparing normalised B-factors instead. Normalisation was per-
formed by dividing individual atomic B-factors by the average B-factor of the
whole data set, quantifying the range of internal ﬂexibility in a structure. This
normalised B-factor can then be compared between different data sets.
Surface plasmon resonance (SPR) analysis. Binding analysis was performed
using a BIAcore 3000™ equipped with a CM5 sensor chip. Approximately 5000 RU
of CD46, CAR, and DSG2 was attached to the CM5 sensor chip, using amine
coupling, at a slow ﬂow-rate of 10 μl/min to ensure uniform distribution on the
chip surface. A blank ﬂow cell was used as a negative control surface on ﬂow cell 1.
All measurements were performed at 25 °C in PBS buffer (Sigma, UK) at a ﬂow rate
of 30 µl/min. For equilibrium binding analysis, the HAdV-D26K and HAdV-B3K
ﬁber knob proteins were puriﬁed and concentrated to 367 and 3 μM respectively.
5× 1:3 serial dilutions were prepared for each sample and injected over the relevant
sensor chip. The equilibrium binding constant (KD) values were calculated
assuming a 1:1 interaction by plotting speciﬁc equilibrium-binding responses
against protein concentrations followed by non-linear least squares ﬁtting of the
Langmuir binding equation. For single cycle kinetic analysis, HAdV-D26K, HAdV-
D48K, HAdV-B35K, HAdV-C5K, and HAdV-B3K were injected at a top con-
centration of around 200 µM, followed by four injections using serial 1:3 dilutions.
The KD values were calculated assuming Langmuir binding (AB= B×ABmax/(KD
+ B)) and the data were analysed using the kinetic titration algorithm (BIAeva-
luationTM 3.1). Receptor proteins were obtained commercially, as follows:
Recombinant Human Desmoglein-2 Fc Chimera Protein, R&D Systems, Catalogue
number 947-DM-100. Recombinant Human CXADR Fc Chimera Protein (CAR),
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R&D Systems, Catalogue number 3336-CX-050. Recombinant Human CD46
Protein (His Tag), Sino Biological, Catalogue number 12239-H08H.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Macromolecular structures generated during this study have been deposited in wwPDB
(worldwide Protein Data Bank; https://www.wwpdb.org/), and have PDB ID’s 6FJN,
6HCN, and 6FJQ. PDB ID’s for macromolecular structures utilised, but not generated in
the course of this study, are as follows: HAdV-B11K in complex with CD46, PDB 3O8E.
HAdV-D37K in complex with CAR-D1, PDB 2J12. HAdV-B35K, PDB 2QLK. Genomic
sequences from which ﬁber-knob domain sequences were determined, which have been
used in phylogenetic analysis, have the following NCBI accession numbers: AC_000017|
AF532578|X73487|AY803294|AB562586|AY601636|AF108105|GU191019|JQ326209|
AC_000007|JN226749|KF528688|FJ404771|JN226750|JN226751|JN226752|EF153474|
JN226753|FJ824826|JN226754|JN226755|AM749299|JN226756|JN226758|AY737797|
AC_000019|GQ384080|JN226759|JN226760|KU162869|DQ315364|JN226761|JN226762|
JN226763|JN226764|AY875648|JN226757|EF153473|DQ393829|AC_000008|AY737798|
JN226765|DQ923122|AB605243|NC_012959|FJ643676|HM770721|HQ413315|
AC_000018|DQ086466|JN226746|JN226747|AB448776|AB448767|AJ854486|KF006344|.
All other data pertaining to this manuscript are available from the authors upon request.
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